Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer - Top-Institutions - MDSpire

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer

  • By

  • Zeynep Irem Ozay

  • Yeonjung Jo

  • Georges Gebrael

  • Micah Ostrowski

  • Vinay Mathew Thomas

  • Haoran Li

  • Ryon P. Graf

  • Soumyajit Roy

  • Benjamin L. Maughan

  • Avirup Guha

  • Irbaz Bin Riaz

  • Emmanuel S. Antonarakis

  • Rana R. McKay

  • Neeraj Agarwal

  • Umang Swami

  • June 24, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Utah
    University of Utah

    Salt Lake City, UT

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #4

    Huntsman Cancer Institute
    Huntsman Cancer Institute

    Salt Lake City, UT

    Key Differentiators

    • Oncology

Original Source(s)

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer

  • by Zeynep Irem Ozay, Yeonjung Jo, Georges Gebrael, Micah Ostrowski, Vinay Mathew Thomas, Haoran Li, Ryon P. Graf, Soumyajit Roy, Benjamin L. Maughan, Avirup Guha, Irbaz Bin Riaz, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami

  • June 24, 2026

Related Content

Metastatic extramammary Paget’s disease successfully treated by trastuzumab deruxtecan: a rare case report

Distribution analysis of gynecological carcinomas with concurrent second primary carcinomas

Metabolic regulation and immunosuppressive functions of lipid-associated macrophages in pancreatic ductal adenocarcinoma